Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fukuda

Showing results (1151-1160 of 1,179) with videos related to

Pageof 118
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 27, 2007
Transforming growth factor-beta(2) polymorphisms are associated with childhood atopic asthmaK Hatsushika, T Hirota, M Harada, et al.
Bone Marrow Transplantation|November 24, 2015
Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomesK Yakushijin, Y Atsuta, N Doki, et al.
Bone Marrow Transplantation|September 4, 2012
Effect of related donor availability on outcome of AML in the context of related and unrelated hematopoietic cell transplantationM Yanada, S Kurosawa, T Yamaguchi, et al.
Bone Marrow Transplantation|April 4, 2017
Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphomaS Yamasaki, R Suzuki, K Hatano, et al.
Tissue Antigens|October 22, 2004
Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long-lasting immunityS Shichijo, N Keicho, H T Long, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progressionK Morimoto, T Yamada, N Furuya, et al.
Leukemia|October 22, 2015
Complex molecular genetic abnormalities involving three or more genetic mutations are important prognostic factors for acute myeloid leukemiaS Wakita, H Yamaguchi, T Ueki, et al.
Bone Marrow Transplantation|June 13, 2017
GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemiaS Terakura, Y Kuwatsuka, S Yamasaki, et al.
Bone Marrow Transplantation|November 18, 2008
Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined studyS-W Kim, S-i Mori, R Tanosaki, et al.
Nature Communications|October 27, 2017
Maximizing T <sub>c</sub> by tuning nematicity and magnetism in FeSe<sub>1-x</sub> S <sub>x</sub> superconductorsK Matsuura, Y Mizukami, Y Arai, et al.
Pageof 118

Showing results (1151-1160 of 1,179) with videos related to

Sort By:
Pageof 118
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 27, 2007
Transforming growth factor-beta(2) polymorphisms are associated with childhood atopic asthmaK Hatsushika, T Hirota, M Harada, et al.
Bone Marrow Transplantation|November 24, 2015
Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomesK Yakushijin, Y Atsuta, N Doki, et al.
Bone Marrow Transplantation|September 4, 2012
Effect of related donor availability on outcome of AML in the context of related and unrelated hematopoietic cell transplantationM Yanada, S Kurosawa, T Yamaguchi, et al.
Bone Marrow Transplantation|April 4, 2017
Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphomaS Yamasaki, R Suzuki, K Hatano, et al.
Tissue Antigens|October 22, 2004
Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long-lasting immunityS Shichijo, N Keicho, H T Long, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progressionK Morimoto, T Yamada, N Furuya, et al.
Leukemia|October 22, 2015
Complex molecular genetic abnormalities involving three or more genetic mutations are important prognostic factors for acute myeloid leukemiaS Wakita, H Yamaguchi, T Ueki, et al.
Bone Marrow Transplantation|June 13, 2017
GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemiaS Terakura, Y Kuwatsuka, S Yamasaki, et al.
Bone Marrow Transplantation|November 18, 2008
Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined studyS-W Kim, S-i Mori, R Tanosaki, et al.
Nature Communications|October 27, 2017
Maximizing T <sub>c</sub> by tuning nematicity and magnetism in FeSe<sub>1-x</sub> S <sub>x</sub> superconductorsK Matsuura, Y Mizukami, Y Arai, et al.
Pageof 118